Furthermore, p53 abnormalities may serve as early indicators of CRC, especially in patients with hereditary syndromes like familial adenomatous polyposis (FAP) and Lynch syndrome, where p53 mutations occur earlier in tumorigenesis. The gene discussed is TP53; the disease is Lynch syndrome.